相关实验视频

Updated: Sep 9, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

利用循环:循环RNA在现代治疗中的前景

Yang-Yang Zhao¹, Fu-Ming Zhu¹, Yong-Juan Zhang¹

¹Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

|August 28, 2025

概括

循环RNAs (circRNAs) 提供了稳定的,较少的免疫治疗潜力. 计算设计和交付平台的进步加速了它们在疫苗和蛋白质替代疗法中的临床应用.

科学领域:

生物技术
分子生物学
有关RNA疗法

背景情况:

循环RNAs (circRNAs) 是一种具有固有的稳定性和低免疫性,由于其独特的闭环结构的新型疗法.
在控制药理动力学和标准化circRNA疗法的制造过程方面仍然存在挑战.
计算设计和模块化交付系统是克服这些障碍和推进临床翻译的关键.

研究的目的:

对循环RNA (circRNA) 疗法的最新进展进行审查.
为疫苗和药物开发分析circRNA的稳定性和免疫性质.
讨论合成策略,交付平台和可扩展circRNA生产的AI驱动优化.

主要方法:

综合了近期关于circRNA疗法的临床前和临床研究.
在疫苗和药物开发背景下对circRNA稳定性和免疫性进行专注分析.
对计算设计,合成策略,交付平台和人工智能驱动的优化进行讨论.

主要成果:

CircRNAs表现出核酶耐药性,降低免疫性和持续的转化活性,使其成为有前途的治疗药物.
计算工具和交付平台之间的新兴协同作用正在加速circRNA疗法的临床转化.
临床前和临床研究强调circRNA在疫苗开发和蛋白质替代疗法的潜力.

结论:

循环RNAs (circRNAs) 代表了下一代生物制剂和精确医学的多功能平台.
它们的固有稳定性和可调节性质将它们定位为强大的表达载体和调节分子.
合成,传递和人工智能驱动的优化方面的持续进步将进一步释放circRNAs的治疗潜力.

关键词:

人工智能支持环RNA疫苗的使用基于circRNA的治疗方法设计策略的免疫反应

更多相关视频

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Use of Alu Element Containing Minigenes to Analyze Circular RNAs

Published on: March 10, 2020

相关概念视频

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

RNA Structure

RNA Structure

The basic structure of RNA consists of a string of ribonucleotides attached by phosphodiester bonds. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA) involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three...

Ribozymes

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.